
    
      To assess the efficacy and safety of Ramosetron, Aprepitant and Dexamethasone therapy versus
      Ondansetron, Aprepitant and Dexamethasone therapy for preventing of nausea and vomiting in
      highly emetogenic chemotherapy (ROAD study):
    
  